Works in Progress editor @salonium explains why Anthropic could become a pharmaceutical company instead of just selling AI to Big Pharma: "So far they’ve announced that they’re working on neglected diseases, which includes tropical diseases like malaria and tuberculosis, and rare diseases, which are often caused by a single gene." "These tend to be areas where the economic incentives aren’t there for drug developers. If there’s a philanthropic way to get involved, I think that’s pretty…